560
Participants
Start Date
June 30, 2003
Primary Completion Date
January 31, 2005
Study Completion Date
January 31, 2005
Paroxetine CR
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, Mount Kisco
GSK Investigational Site, Philadelphia
GSK Investigational Site, Philadelphia
GSK Investigational Site, Conshohocken
GSK Investigational Site, Rockville
GSK Investigational Site, Gaithersburg
GSK Investigational Site, Greensboro
GSK Investigational Site, Raleigh
GSK Investigational Site, Charlotte
GSK Investigational Site, Charleston
GSK Investigational Site, Marietta
GSK Investigational Site, Jacksonville
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, West Palm Beach
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Sebring
GSK Investigational Site, Leesburg
GSK Investigational Site, Memphis
GSK Investigational Site, Lafayette
GSK Investigational Site, Prairie Village
GSK Investigational Site, Overland Park
GSK Investigational Site, Little Rock
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Houston
GSK Investigational Site, Austin
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Boise
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Los Angeles
GSK Investigational Site, Beverly Hills
GSK Investigational Site, El Centro
GSK Investigational Site, Redlands
GSK Investigational Site, Santa Ana
GSK Investigational Site, Anaheim
GSK Investigational Site, Eugene
GSK Investigational Site, Norwich
GSK Investigational Site, Braintree
GSK Investigational Site, Nashua
GSK Investigational Site, Clementon
GSK Investigational Site, Princeton
GSK Investigational Site, East Providence
GSK Investigational Site, San Antonio
Lead Sponsor
GlaxoSmithKline
INDUSTRY